These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 16810629)
21. Tadalafil (Adcirca) for pulmonary arterial hypertension. Med Lett Drugs Ther; 2009 Nov; 51(1324):87-8. PubMed ID: 19890245 [No Abstract] [Full Text] [Related]
22. [Pulmonary hypertension in COPD and interstitial lung diseases]. Markart P; Ghofrani HA; Grimminger F; Günther A Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606 [TBL] [Abstract][Full Text] [Related]
23. Current therapies for pulmonary arterial hypertension. Takaoka S; Faul JL; Doyle R Semin Cardiothorac Vasc Anesth; 2007 Jun; 11(2):137-48. PubMed ID: 17536117 [TBL] [Abstract][Full Text] [Related]
24. [Current recommendations for the diagnosis and treatment of pulmonary hypertension]. Olschewski H Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S334-7. PubMed ID: 17139601 [TBL] [Abstract][Full Text] [Related]
25. Epoprostenol use in a National Pulmonary Hypertension Centre from 1997 to 2007. Church AC; Sanabria D; Peacock A; Johnson M Thorax; 2009 Jul; 64(7):642. PubMed ID: 19561289 [No Abstract] [Full Text] [Related]
26. Conventional and targeted medical therapies. Barst RJ; Stewart D Cardiol Young; 2009 May; 19 Suppl 1():28-34. PubMed ID: 19419603 [No Abstract] [Full Text] [Related]
30. Pulmonary hypertension: its diagnosis and management, a multidisciplinary approach. Vonk MC; van Dijk AP; Heijdra YF; van der Heijden HF; Bredie SJ; van den Hoogen FH Neth J Med; 2005 Jun; 63(6):193-8. PubMed ID: 16011010 [TBL] [Abstract][Full Text] [Related]
31. Patient safety challenges in treprostinil therapy. Roncesvalles A; Lee FW; Camamo J; Priestley G Medsurg Nurs; 2008 Apr; 17(2):101-6. PubMed ID: 18517170 [TBL] [Abstract][Full Text] [Related]
32. How to manage primary pulmonary hypertension. Giving hope to patients with a life-threatening illness. Ricciardi MJ; Rubenfire M Postgrad Med; 1999 Mar; 105(3):45-8, 51-6. PubMed ID: 10086033 [TBL] [Abstract][Full Text] [Related]
37. [Dana Point: what is new in the treatment of pulmonary hypertension?]. Hoeper MM; Ghofrani HA; Grimminger F; Rosenkranz S Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S191-5. PubMed ID: 18814094 [TBL] [Abstract][Full Text] [Related]
38. [The treatment of pulmonary arterial hypertension associated with chronic obstructive pulmonary disease makes sense - contra]. Köhler D Dtsch Med Wochenschr; 2008 Apr; 133(14):721. PubMed ID: 18363193 [No Abstract] [Full Text] [Related]
39. Effects of epoprostenol on pulmonary hypertension after pneumonectomy for trauma. Brevard S; Weintraub SL; Bronaugh H; Hunt JP; Marr AB J Trauma; 2008 Feb; 64(2):496-9. PubMed ID: 18301220 [No Abstract] [Full Text] [Related]